The therapy offers new hope in solid tumor treatment with fewer adverse effects.
Education about prevention measures and early signs and symptoms of the condition are crucial
The clinical trial success in canines may have broader implications for applicability.
Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
Pharmacists can leverage their own identities to advocate for happier, healthier individuals within communities of different ethnic and socioeconomic backgrounds
As pharmacy professionals battle with their own challenges regarding mental health, the optimal role of psychiatric pharmacists is yet to be defined.
Cannabis use during pregnancy may harm fetal development and long-term health.
Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.
Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Find nontraditional financing streams, identify optimal learning materials to dive into this growing space.
A compliance officer role represents an exciting new challenge to ensure safe handling in compliance with United States Pharmacopeia.
Health care is inherently human, so digital health care technology aimed at advancing human health needs empathy to be successful.
Cerebral adrenoleukodystrophy is a progressive neurodegenerative disease causes irreversible neurologic decline and can result in functional disabilities, such hearing loss and cortical blindness.
New COVID-19 variants are always cause for concern but are not a cause for panic.
By educating their patients on the provisions of the Inflation Reduction Act, pharmacists can have an even greater impact by increasing vaccine uptake in historically underserved groups.
During a recent roundtable discussion, industry leaders shared frontline insights on the biggest drug diversion challenges.
Many pharmacies and safety-net providers were preparing for the long-anticipated transition from Medicaid managed care to fee-for-service (FFS)—known as the carve-out—that was set to take effect on May 1, 2021.
The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.
As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.
Pharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.
Combining tramadol and celecoxib into a co-crystal of celecoxib-tramadol provides peripherally and centrally mediated analgesia.
Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.
FDA approves groundbreaking gene therapies for sickle cell disease, revolutionizing treatment.
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Although OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.
Students are being exposed to new patient experiences through collaboration with practitioners.
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.